rs121913297
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000321.3(RB1):c.2242G>A(p.Glu748Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000188 in 1,599,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E748D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000321.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary retinoblastomaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- retinoblastomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- melanomaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RB1 | NM_000321.3 | c.2242G>A | p.Glu748Lys | missense_variant | Exon 22 of 27 | ENST00000267163.6 | NP_000312.2 | |
| RB1 | NM_001407165.1 | c.2242G>A | p.Glu748Lys | missense_variant | Exon 22 of 27 | NP_001394094.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000681 AC: 1AN: 146860Hom.: 0 Cov.: 28 show subpopulations
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452914Hom.: 0 Cov.: 36 AF XY: 0.00000138 AC XY: 1AN XY: 722630 show subpopulations
GnomAD4 genome AF: 0.00000681 AC: 1AN: 146860Hom.: 0 Cov.: 28 AF XY: 0.0000141 AC XY: 1AN XY: 71154 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Retinoblastoma Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 748 of the RB1 protein (p.Glu748Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 527926). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt RB1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.E748K variant (also known as c.2242G>A), located in coding exon 22 of the RB1 gene, results from a G to A substitution at nucleotide position 2242. The glutamic acid at codon 748 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at